New StockGoodie Profile $PLPL 12/0
Post# of 25327
12/09/2013 Breaking News
Plandai Biotechnology, Inc. to Focus Marijuana Research on Neuron Disorders Including Alzheimer's, Parkinson's, and Multiple Sclerosis
Plandai continues research in the medical marijuana field with Newly Acquired Subsidiary Cannabis Biosciences Inc.
The company says its in progress with its recently announced subsidiary, Cannabis Biosciences, Inc., and the development and testing of a botanical extract derived from cannabis.
Quote:
Company Chairman and Chief Executive Officer, Roger Duffield said, "We believe that the phytonutrients in cannabis show excellent potential for treating and preventing a host of neuron and injury related brain diseases including Parkinson's, Alzheimer's, ALS, MS, and post-concussion syndrome, diabetes and more.
Read More